CloudCath today announced that it received FDA 510(k) clearance for its CloudCath remote monitoring system for peritoneal dialysis patients. San Francisco-based CloudCath designed the monitoring system as a data-driven, cloud-based, remote monitoring platform for at-home monitoring of peritoneal dialysis. It uses continuous analytics with its technology to integrate seamlessly into a patient’s daily PD protocol, […]
Avista Capital Partners to acquire Probo Medical
Avista Capital Partners today announced it has entered into a definitive agreement to acquire Probo Medical for an undisclosed amount. Varsity Healthcare Partners’ Probo Medical is a Tampa-based medical imaging company that sells and repairs ultrasound probes. It has 14 facilities in the U.S. in Europe and has a global supply chain. Get the full story on our […]
3M expects single-digit growth in 2022 as disposable respirator demand slows
3M (NYSE:MMM) today told investors that it is projecting single-digit growth for the 2022 fiscal year as respirator mask demand slows. The Maplewood, Minnesota-based manufacturing and material science giant said in its Virtual Strategic Update that it expects organic sales growth in the range of 2% to 5% for this fiscal year. It estimates earnings to […]
CroíValve raises more than $9M in Series A round
CroíValve this week announced that it raised €8 million ($9 million) in a Series A fundraising round to support a feasibility clinical study of its tricuspid valve system. The Dublin-baed company designed its Duo coaptation valve system to treat tricuspid regurgitation (TR), which is a severe heart condition that occurs when the tricuspid valve fails […]
Bio-Rad beats The Street in Q4, despite nearly $1.6B loss
Bio-Rad posted fourth-quarter results that beat the overall consensus on Wall Street. The Hercules, California–based clinical diagnostics company yesterday evening reported losses of $1.573 billion, or $52.59 per share, on sales of $732.8 million for the three months ended Dec. 31, 2021. In comparison, the company earned $839.1 million, or $27.81 pers share off sales […]
Ra Medical Systems wins patent for laser ablation support catheter
Ra Medical Systems today said it received a patent from the U.S. Patent and Trademark Office for a support catheter used with a small flexible liquid core catheter for laser ablation. The Carlsbad, California-based company was granted its 10th patent for the support catheter that is to be used in conjunction with the Dabra liquid […]
Isoray grows sales 19% in Q2 results
Isoray (NYSE:ISR) posted second-quarter results this week that were in line with estimates on Wall Street. The Richland, Washington–based brachytherapy company reported losses of $1.6 million, or -1¢ per share, on sales of $2.82 million for the three months ended Dec. 31, 2021, for a sales growth of 19.4% compared with Q2 2021. Earnings per […]
Electromed beats The Street in Q2 results
Electromed (NYSE:ELMD) posted second-quarter results this week that beat the overall consensus on Wall Street. The New Prague, Minnesota–based airway clearance maker reported profits of $838,000, or 10¢ per share, on sales of $10.2 million for the three months ended Dec. 31, 2021, for a sales growth of 7.92% compared with Q2 2021. Earnings per […]
Glaukos announces executive leadership changes
Glaukos this week announced several executive leadership changes that will take place on April 1. Joseph Gilliam is appointed as president and COO. He previously served as the CFO and SVP of corporate development for the San Clemente, California-based ophthalmic medtech and pharma company since 2017. Here are Glaukos’ new executive committee appointments: Chris Calcaterra […]
CereVasc wins FDA IDE approval to begin eShunt pilot study
CereVasc today announced that it received an FDA investigational device exemption approval to begin a trial of the eShunt for normal pressure hydrocephalus. The Boston-based company can initiate its pilot trial of the eShunt system in patients with normal pressure hydrocephalus (NPH). The eShunt device offers a minimally invasive treatment with the potential to result in […]
Vyaire Medical voluntarily recalls some Bellavista ventilators
Vyaire Medical recently announced that its subsidiary ImtMedical has initiated a voluntary field correction for certain BellaVista ventilators. The company reported a potential issue with BellaVista 1000 and 1000e ventilators that have specific software and configuration combinations that can cease ventilation and generate a technical failure alarm. The issue affects ventilators distributed between Mar. 21, […]